Support our work
DONATE NOW

DEBATE: should be RT still part of treatment for Hodgkin lymphoma? (Part I)

E-session 449 / CME accredited Add to My Agenda

Expert:

Astrid Pavlovsky, expert of session 'DEBATE: should be  RT still part of treatment for Hodgkin lymphoma? (Part I)'

Astrid Pavlovsky
Clinical Research Center - FUNDALEU
Buenos Aires, Argentina

Expert:

Umberto Ricardi, expert of session 'DEBATE: should be  RT still part of treatment for Hodgkin lymphoma? (Part I)'

Umberto Ricardi
University of Turin
Turin, Italy

Discussant: Pierfrancesco Franco, Radiation Oncologist
University of Turin School of Medicine, Turin, Italy

View slides

Enter the recorded session

Share on:

26
Jul 2018
18:15-19:00 CET

Top